Global Oocyte Retrieval Products Market Overview:
Egg retrieval is also known as egg retrieval. Egg retrieval is a procedure in which viable eggs are removed from the ovaries for the in Vitro fertilization process. Egg retrieval is an important part of the Vitro fertilization process, so the growth in IVF procedures is expected to drive demand for egg retrieval products. The high success rate and continuous technological progress are also some of the factors that have further supported the demand for these products. Factors such as high infertility rates and government initiatives to offer better health insurance coverage for IVF procedures are expected to further increase demand for egg retrieval products. To capitalize on the growth opportunities in the egg collection products market, product manufacturers are focusing on introducing improved products that provide doctors with better precision during the procedure, which in turn reduces patient pain throughout the procedure and provides effective treatment.
- A Rise in Infertility Rates
- The High Success Rate of the IVF Procedure
- The Growth in the Number of IVF Clinics in Developing Regions
- Lower Cost of IVF Treatments
- High Cost of the Oocyte Retrieval Procedure
- The Complications Associated With the Egg Retrieval Procedure Such As Infection and Pain in the Pelvis and the Ovaries
- The Growing Fertility Tourism
- Rising Technological Advancements in Healthcare Industry
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.
Some of the key players profiled in the report are CooperSurgical Inc. (United States), Vitrolife (Sweden), Gynotech BV (Netherlands), Kitazato Corporation (Japan), Cook Medical (United States), BIOPSYBELL S.R.L. (Italy), weLLgo Medical Products GmbH (Germany), Shanghai Horizon Medical Co. Ltd. (China), Rocket Medical plc (United Kingdom) and Planer Limited (United Kingdom). Analyst at AMA Research see European Players to retain maximum share of Global Oocyte Retrieval Products market by 2026. Considering Market by Technology, the sub-segment i.e. Fresh Embryo IVF will boost the Oocyte Retrieval Products market. Considering Market by Sales Channel, the sub-segment i.e. Online will boost the Oocyte Retrieval Products market.
Latest Market Insights:
In April 2018, Kitazato Corporation had entered into a strategic partnership with SPECTRUN, one of the distributors in Brazil, to supply various assisted technology products such as egg collection needles and related devices.
In January 2021, Shanghai Horizon Medical Co., Ltd. Horizon Medical had received approval for its egg aspiration needle from the Thai Food and Drug Administration (TFDA). This makes it the first product to receive international approval.
What Can be Explored with the Oocyte Retrieval Products Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Oocyte Retrieval Products Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Oocyte Retrieval Products
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Oocyte Retrieval Products market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Oocyte Retrieval Products market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Oocyte Retrieval Products, Government Regulatory and Research Organizations and End-Use Industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Frequently Asked Questions (FAQ):1. What is the growth rate predicted for the Global Oocyte Retrieval Products Market?
The Oocyte Retrieval Products market is expected to see a CAGR of % during projected year 2020 to 2026.
2. Who are the top performing companies in Oocyte Retrieval Products Market?
Top performing companies in the Global Oocyte Retrieval Products market are CooperSurgical Inc. (United States), Vitrolife (Sweden), Gynotech BV (Netherlands), Kitazato Corporation (Japan), Cook Medical (United States), BIOPSYBELL S.R.L. (Italy), weLLgo Medical Products GmbH (Germany), Shanghai Horizon Medical Co. Ltd. (China), Rocket Medical plc (United Kingdom) and Planer Limited (United Kingdom), to name a few.
3. What trending factors would impact Oocyte Retrieval Products Market growth most?
"Availability of Wider Treatment Options and Shorter Waiting Times
" is seen as one of major influencing trends for Oocyte Retrieval Products Market during projected period 2020-2026.